Testing the Addition of the Anti-cancer Viral Therapy Telomelysin⢠to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
NRG Oncology
NRG Oncology
Inhibrx Biosciences, Inc
Innovent Biologics (Suzhou) Co. Ltd.
Blokhin's Russian Cancer Research Center
Memorial Sloan Kettering Cancer Center